^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Zinbryta (daclizumab)

    i
    Associations
    News

    Trials

    Company:
    AbbVie, Biogen
    Drug class:
    CD25 inhibitor, IL-2R antagonist
    Related drugs:
    Associations
    News

    Trials

    Apply
    Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery (ZAP IT) (NCT00626015)
    Phase 1
    John Sampson
    Completed
    Last update posted :
    01/21/2016
    Initiation :
    03/01/2007
    Primary completion :
    02/01/2013
    Completion :
    02/01/2013
    IL2RA • CD4 • IL7R • ISG20
    |
    EGFRvIII expression
    |
    temozolomide • Rintega (rindopepimut) • Simulect (basiliximab) • Zinbryta (daclizumab)